WebSorafenib显著抑制NIH 3T3细胞中VEGFR2磷酸化,IC50 为 30 nM,也会抑制HEK-293细胞中Flt-3磷酸化,IC50 为20 nM。Sorafenib有效阻断大多数细胞中MEK 1/2 和 ERK 1/2 … WebAfter treatment with sorafenib at concentrations ranging from 0 to 20 µM on HCC cell lines HepG2, Huh7 and Hep3B for 72h, cell viability was determined using MTS dye solution. …
Sorafenib (BAY 43-9006) tosylate ≥99%(HPLC) Selleck Raf …
Web11 jan. 2024 · Sorafenib (Bay 43-9006) 是有效的多激酶抑制剂,抑制Raf-1,B-Raf 和 VEGFR-3 的 IC50 分别为6 nM,20 nM,22 nM。 索拉非尼作用 索拉非尼是一种靶向生 … Web生物活性. Sorafenib tosylate (BAY 43-9006 tosylate,NSC-724772 tosylate) is a multikinase inhibitor of Raf-1 and B-Raf with IC50 of 6 nM and 22 nM in cell-free assays, … lagu rohani doa seorang anak
Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor …
WebSupplementary Fig. S1 Induction of sorafenib resistance by YB -1 in hepatocarcinoma cell lines. (A) The IC50 values of sorafenib were detected by CCK-8 assays in four HCC cell … Web1. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. L Liu, Y Cao, C Chen, X Zhang, A McNabola, D Wilkie Cancer research, 2006 2. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. GK Abou-Alfa, L Schwartz, S Ricci. WebFirst, HepG2, HepG2-LR, Huh7 cell and Huh7-LR cells were seeded into 6-well palates at a density of 500 cells/per well and then treated with lenvatinib or Sophoridine for 24 hours. … jefe juan\u0027s portland maine